Study Stopped
Difficulty in purchasing reagents and receiving consent from the subject
The Correlation Between Renal Injury and Biomarkers in Pediatric Ureteropelvic Junction Obstruction Patients
1 other identifier
observational
N/A
1 country
1
Brief Summary
Urinary Neutrophil gelatinase associated lipocalin (NGAL) has been recently reported to be related with the degree of hydronephrosis in pediatric ureteropelvic junction obstruction (UPJO) patients. We are trying to analyze whether it is related with the grade of renal injury in UPJO patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 17, 2012
CompletedFirst Posted
Study publicly available on registry
October 23, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedMay 6, 2021
May 1, 2021
Same day
October 17, 2012
May 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The level of urinary NGAL and the degree of renal injury
Analysis of correlation between the level of urinary NGAL and the degree of renal injury
6 month after operation
Study Arms (3)
UPJO
0-3 year old hydronephrosis patients without ureter dilatation who undergo pyeloplasty
Hydronephrosis
0-3 year old hydronephrosis patients without ureter dilatation who does not meet the indication of pyeloplasty
Normal
0-3 year old children without hydronephrosis
Eligibility Criteria
Group 1: 20 patients with UPJO undergo pyeloplasty Group 2: 20 patients with hydronephrosis who does not meet the indication of pyeloplasty Group 3: 20 normal control
You may qualify if:
- \<Group 1\>
- year old patients with SFU grade 2 or more hydronephrosis without ureteral dilatation
- needs pyeloplasty due to differential renal function (DRF)\<40%, decreased DRF by more than 5%, development of urinary tract infection, development of urinary stone, and development of pain related with UPJO \<Group 2\>
- \. 0-3 year old patients with SFU grade 3 or 4 hydronephrosis without ureteral dilatation 2. doesn't meet the above criteria for the indication of pyeloplasty \<Group 3\>
- \. 0-3 year old children without any abnormality of urinary tract
You may not qualify if:
- \<Group 1\>
- patients with contralateral disease affecting DRF
- history of previous urinary tract surgery
- follow up loss before diuretic renogram performed at 6-12 months from operation \<Group 2, 3\>
- \. patients with contralateral disease affecting DRF 2. history of previous urinary tract surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Urology, Urological Science Institute, Yonsei University, Colleage of Medicine
Seoul, 120-752, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 17, 2012
First Posted
October 23, 2012
Study Start
August 1, 2012
Primary Completion
August 1, 2012
Study Completion
August 1, 2013
Last Updated
May 6, 2021
Record last verified: 2021-05